Since 2019, calls to Poison Control centers around the globe have skyrocketed because of medication errors related to GLP-1 agonists like Ozempic Mounjaro, and Wegovy. The products from regulated drug manufacturers come in a pen with easy to read dosages and a simple turn/click dosing system, whereas compounded formulations require patients to read and understand drug and syringe measurements and concentrations, while also relying on them to draw up the correct dosage and administer it properly with very little guidance. If you take these medications or care for someone who does, it’s important to understand their safety concerns and side effects in the event of a medication error. ##weightloss##health##medicine##pharmacy##glp1
As someone who has worked closely with patients using GLP-1 agonists, I’ve witnessed firsthand how important proper education and guidance are for safely managing these medications. GLP-1 agonists such as Ozempic, Mounjaro, and Wegovy play a vital role in not only weight loss but also blood sugar regulation by mimicking a hormone that controls appetite and glucose metabolism. However, because some patients receive compounded versions instead of prefilled pens, the risk of dosing errors significantly increases. In my experience, the complicated process of drawing up the medication using syringes without clear dosage instructions often leads to confusion and accidental overdosing. Patients then experience intensified side effects like nausea, vomiting, abdominal pain, and diarrhea. I always advise patients to think of this as similar to food poisoning—while unpleasant, these symptoms usually resolve within a few hours or days if properly managed. Another key point I’ve learned is that hypoglycemia (low blood sugar) is generally not caused by GLP-1 agonists alone but occurs mainly in patients who also take other glucose-lowering drugs such as insulin or metformin. This means that careful monitoring of all medications is essential to avoid dangerous blood sugar drops. Importantly, there is no direct antidote for GLP-1 agonist overdose. Emergency rooms typically provide supportive care including IV fluids and medications to control nausea and vomiting. The best approach to prevent complications is to stay hydrated and not restart the medication until adverse symptoms subside. For anyone unsure about how to properly administer these injections or concerned about dosing accuracy, I highly recommend bringing your medication and syringes to a pharmacist or healthcare provider. They can demonstrate proper technique or even help draw up the correct dose to avoid errors. Additionally, Poison Control centers remain a reliable resource for questions or urgent concerns related to these drugs. Ultimately, while GLP-1 agonists offer powerful benefits in weight management and diabetes control, their safe use requires clear, accessible instructions and patient support. Ensuring you understand your medication can greatly reduce the chance of errors and help you manage side effects effectively.
